Cargando…
Updates on HTLV-1 Uveitis
HTLV-1 uveitis (HU) is the third clinical entity to be designated as an HTLV-1-associated disease. Although HU is considered to be the second-most frequent HTLV-1-associated disease in Japan, information on HU is limited compared to that on adult T-cell leukemia/lymphoma (ATL) and HTLV-1-associated...
Autores principales: | Kamoi, Koju, Watanabe, Toshiki, Uchimaru, Kaoru, Okayama, Akihiko, Kato, Seiko, Kawamata, Toyotaka, Kurozumi-Karube, Hisako, Horiguchi, Noe, Zong, Yuan, Yamano, Yoshihisa, Hamaguchi, Isao, Nannya, Yasuhito, Tojo, Arinobu, Ohno-Matsui, Kyoko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9030471/ https://www.ncbi.nlm.nih.gov/pubmed/35458524 http://dx.doi.org/10.3390/v14040794 |
Ejemplares similares
-
Mechanism of Secondary Glaucoma Development in HTLV-1 Uveitis
por: Zong, Yuan, et al.
Publicado: (2022) -
In vitro Evaluation of the Safety of Adalimumab for the Eye Under HTLV-1 Infection Status: A Preliminary Study
por: Kurozumi-Karube, Hisako, et al.
Publicado: (2020) -
A 10-year follow-up of infliximab monotherapy for refractory uveitis in Behçet’s syndrome
por: Horiguchi, Noe, et al.
Publicado: (2020) -
Adult T-Cell Leukemia/Lymphoma-Related Ocular Manifestations: Analysis of the First Large-Scale Nationwide Survey
por: Kamoi, Koju, et al.
Publicado: (2019) -
HTLV-1 uveitis
por: Kamoi, Koju, et al.
Publicado: (2012)